Clinical Trial Detail
Home > Clinical Trial Detail
Detail Information Last Updated: 28-May-2024
Identifier No. : eCTS-2024-074


Certificate Holder : Cheuk, Ka Leung Daniel
Protocol Title : An open label complex clinical trial in newly diagnosed pediatric de novo AML patients – a study by the NOPHO-DB-SHIP consortium
Protocol No. : CHIP-AML22/Master
Trial Drug : Gemtuzumab ozogamicin Inj., Etoposide Inj., Cytarabine Inj., Mitoxantrone Inj., Daunorubicin Inj., Fludarabine Inj., Methotrexate Inj.


Trial Site Principal Investigator
Hong Kong Children's Hospital Dr. CHEUK, KA LEUNG DANIEL